Welcome to our dedicated page for Vislink Technologies SEC filings (Ticker: VISL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vislink Technologies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vislink Technologies's regulatory disclosures and financial reporting.
Vislink Technologies (NASDAQ: VISL) received an Amendment No. 4 to Schedule 13D from a group of Hale-affiliated entities dated 29 June 2025, reflecting ownership positions as of 12 June 2025.
The filing lists seven reporting persons—Hale Capital Partners LP, Hale Capital Management LP, Hale Fund Management LLC, Hale Fund Partners LLC, Hale Fund Partners II LLC, Hale Capital Partners Fund V LP and Martin M. Hale Jr.—who together report beneficial ownership of 416,503 common shares. This represents 16.9 % of Vislink’s outstanding stock. The bulk of the position is held through Fund V (352,822 shares, 14.3 %) and attributed to Mr. Hale via shared voting and dispositive power. Hale Capital Partners LP and Hale Fund Partners LLC each hold 63,681 shares (2.6 %).
The amendment states that, except as described, all previously reported information in the original 13D (filed 12 Feb 2025) remains unchanged. No new legal proceedings, risk factors or additional financing activities are disclosed, and the purpose of the transaction section is not amended in the excerpt provided.